Bearish
Pfizer's stock declines 1.4% to $27.66 amid investor concerns over revenue and dividends.
In the past 24 hours, Pfizer's stock price fell by 1.4% to $27.66, reflecting investor concerns over declining post-pandemic revenue and the sustainability of its dividend yield. Analysts maintain a consensus 'Hold' rating with an average price target of $28.28.
Key points
- Pfizer's stock price declines 1.4% to $27.66 amid investor concerns over revenue and dividends.
- Analysts maintain a consensus 'Hold' rating with an average price target of $28.28.
Sources
AI-generated from public news sources. Not financial advice.
